title: Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer.
authors.affiliation: Beth Israel Deaconess Medical Center, Boston, MA ntung@bidmc.harvard.edu.
authors.forename: Nadine M
authors.initials: NM
authors.lastname: Tung
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Eric P
authors.initials: EP
authors.lastname: Winer
mesh_terms: D016190:Carboplatin / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D005260:Female; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000378:metabolism*; D020360:Neoadjuvant Therapy / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy*
chemical_list: D016190:Carboplatin; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human